CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM)
Rubaida Shakeel is an accomplished researcher currently serving as a PhD Scholar at the CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM) since August 2019, focusing on epigenetics, target-based drug discovery involving HMT and notch inhibition, and stem cell biology. Prior experience includes a position as a DST Junior Research Fellow at CSIR-IIIM from April 2017 to March 2019, as well as serving as a research scholar during the M.Phil program in Biotechnology at Baba Ghulam Shah Badshah University from March 2015 to December 2016. Rubaida completed a Master's degree in Biochemistry at the University of Kashmir from April 2011 to June 2013 and holds a Bachelor's degree in Science, along with a one-year diploma in Medicinal Chemistry from Islamia College of Science and Commerce.
This person is not in any teams
CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM)
Indian Institute of Integrative Medicine (IIIM) is a national Institute of the Council of Scientific & Industrial Research (CSIR) of India. The mandate of IIIM is to be an internationally competitive centre of excellence in all facets of natural products research and technology, including (a) discovery of novel pharmacologically active natural products from plants and microbial species and translating them into drug leads and candidates by medicinal chemistry, preclinical pharmacology and clinical development. This approach is pursued both in NCE as well as botanical herbal mode; (b) Preclinical and clinical validation and establishment of mechanism of action of drugs used in various Indian systems of Medicines (Ayurveda, Unani, Siddha and other Indigenous systems of medicine); (c) develop agro-technologies and commercial cultivation of high value medicinal and aromatic plants from Western Himalayas including Kashmir Valley and Laddkh for national and international markets; and (d) to work with Indian and global pharmaceutical industry to out-license new products and technologies.